In this approach, the initial antigen, exclusively expressed on brain or GBM cells, primes the T cells to induce the expression of a CAR-targeting antigens such as IL-13Rα2 and EphA2, thus eliminating GBM cells expressing either EphA2 or IL-13Rα2. Here, EPHA2 is linked to glioblastoma.